Asieris Pharmaceuticals
company
About
Asieris Pharmaceuticals is a Chinese biotech company.
- 101 - 250
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥700M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥1.09B
Asieris Pharmaceuticals has raised a total of
¥1.09B
in funding over 2 rounds. Their latest funding was raised on
Nov 11, 2020 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 11, 2020 | Series D | ¥700M | 3 | — | — | Detail |
| Jun 28, 2020 | Series C | ¥290M | 1 | — | — | Detail |
| Dec 29, 2017 | Series B | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
5
Asieris Pharmaceuticals is funded by 5 investors.
Haoshuo Zhier Fund
and IFSC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
IFSC
|
— | Series D |
Homsun Capital
|
— | Series D |
|
|
— | Series C |
Phoenix Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
